| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plant Extracts | 9 | 2021 | 303 | 2.440 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 10 | 2021 | 28 | 2.120 |
Why?
|
| Lactic Acid | 9 | 2021 | 110 | 1.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 933 | 1.530 |
Why?
|
| High-Throughput Screening Assays | 6 | 2021 | 72 | 1.480 |
Why?
|
| Glycolysis | 9 | 2021 | 71 | 1.360 |
Why?
|
| Biological Products | 3 | 2016 | 91 | 1.320 |
Why?
|
| Cell Survival | 24 | 2021 | 934 | 1.280 |
Why?
|
| Cell Line, Tumor | 25 | 2025 | 2598 | 1.140 |
Why?
|
| Glioma | 7 | 2016 | 92 | 1.110 |
Why?
|
| Hydroxamic Acids | 2 | 2018 | 34 | 1.090 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2018 | 44 | 1.070 |
Why?
|
| Neuroblastoma | 11 | 2012 | 134 | 1.060 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 2021 | 64 | 0.960 |
Why?
|
| Cytostatic Agents | 2 | 2021 | 6 | 0.910 |
Why?
|
| Monoamine Oxidase | 5 | 2012 | 36 | 0.840 |
Why?
|
| Mitochondria | 8 | 2012 | 516 | 0.820 |
Why?
|
| Plants, Medicinal | 4 | 2013 | 60 | 0.810 |
Why?
|
| Antineoplastic Agents, Phytogenic | 5 | 2021 | 134 | 0.790 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2017 | 184 | 0.780 |
Why?
|
| Glucose | 7 | 2020 | 242 | 0.780 |
Why?
|
| Environment | 2 | 2014 | 148 | 0.740 |
Why?
|
| Dioscorea | 1 | 2021 | 4 | 0.730 |
Why?
|
| Thiophenes | 1 | 2021 | 30 | 0.720 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 683 | 0.710 |
Why?
|
| Pyridones | 1 | 2021 | 50 | 0.700 |
Why?
|
| Herbicides | 2 | 2012 | 44 | 0.690 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2020 | 4 | 0.680 |
Why?
|
| Nitric Oxide Synthase | 5 | 2005 | 134 | 0.670 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 274 | 0.660 |
Why?
|
| Hydrogen Peroxide | 7 | 2012 | 193 | 0.640 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 1679 | 0.630 |
Why?
|
| Gene Expression | 2 | 2021 | 692 | 0.600 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 24 | 0.580 |
Why?
|
| Imidazoles | 2 | 2018 | 138 | 0.570 |
Why?
|
| Microglia | 3 | 2016 | 204 | 0.560 |
Why?
|
| Boswellia | 1 | 2017 | 2 | 0.560 |
Why?
|
| Naphthoquinones | 1 | 2018 | 41 | 0.560 |
Why?
|
| Triterpenes | 1 | 2017 | 18 | 0.550 |
Why?
|
| Neurons | 4 | 2018 | 1246 | 0.540 |
Why?
|
| Cytokines | 3 | 2020 | 661 | 0.540 |
Why?
|
| Animals | 37 | 2019 | 16695 | 0.530 |
Why?
|
| Melanoma | 1 | 2018 | 109 | 0.530 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 12 | 0.520 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 17 | 0.520 |
Why?
|
| Antioxidants | 6 | 2015 | 439 | 0.510 |
Why?
|
| Seeds | 1 | 2017 | 46 | 0.510 |
Why?
|
| Vitis | 1 | 2017 | 37 | 0.500 |
Why?
|
| Momordica | 2 | 2019 | 14 | 0.500 |
Why?
|
| Nerve Growth Factor | 2 | 2018 | 28 | 0.500 |
Why?
|
| Rats | 22 | 2019 | 3701 | 0.490 |
Why?
|
| Signal Transduction | 6 | 2018 | 2111 | 0.490 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2017 | 1112 | 0.480 |
Why?
|
| Sepsis | 1 | 2016 | 90 | 0.480 |
Why?
|
| Humans | 32 | 2025 | 42163 | 0.450 |
Why?
|
| Neoplasms | 2 | 2020 | 1341 | 0.450 |
Why?
|
| Dopamine | 6 | 2004 | 272 | 0.450 |
Why?
|
| Neurogenesis | 1 | 2015 | 64 | 0.450 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 379 | 0.440 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2014 | 36 | 0.430 |
Why?
|
| Tumor Cells, Cultured | 10 | 2014 | 506 | 0.430 |
Why?
|
| Lipopolysaccharides | 8 | 2016 | 235 | 0.420 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 2012 | 27 | 0.420 |
Why?
|
| Escherichia coli | 1 | 2016 | 461 | 0.420 |
Why?
|
| Models, Biological | 3 | 2014 | 711 | 0.410 |
Why?
|
| Pyruvic Acid | 2 | 2003 | 21 | 0.400 |
Why?
|
| Macrophages | 2 | 2016 | 515 | 0.400 |
Why?
|
| Cadmium Compounds | 1 | 2013 | 7 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 415 | 0.400 |
Why?
|
| Selenium Compounds | 1 | 2013 | 11 | 0.400 |
Why?
|
| Neuroglia | 2 | 2005 | 131 | 0.390 |
Why?
|
| Organic Chemicals | 1 | 2013 | 35 | 0.390 |
Why?
|
| Nanocomposites | 1 | 2013 | 23 | 0.390 |
Why?
|
| Ecosystem | 1 | 2014 | 171 | 0.390 |
Why?
|
| Mitosis | 1 | 2013 | 112 | 0.380 |
Why?
|
| Reactive Oxygen Species | 6 | 2018 | 518 | 0.380 |
Why?
|
| Oxidative Phosphorylation | 2 | 2010 | 56 | 0.370 |
Why?
|
| Mice | 13 | 2016 | 6490 | 0.360 |
Why?
|
| Genome | 1 | 2012 | 149 | 0.350 |
Why?
|
| Antineoplastic Agents | 5 | 2025 | 979 | 0.350 |
Why?
|
| Astrocytes | 3 | 2015 | 244 | 0.350 |
Why?
|
| MicroRNAs | 1 | 2017 | 501 | 0.340 |
Why?
|
| Parkinson Disease | 2 | 2011 | 207 | 0.330 |
Why?
|
| Homeostasis | 1 | 2012 | 193 | 0.330 |
Why?
|
| Chemokine CCL2 | 3 | 2017 | 95 | 0.330 |
Why?
|
| Acids | 1 | 2009 | 19 | 0.310 |
Why?
|
| Disulfides | 3 | 2015 | 92 | 0.310 |
Why?
|
| Cocaine | 6 | 2018 | 248 | 0.300 |
Why?
|
| Benzoquinones | 2 | 2021 | 38 | 0.300 |
Why?
|
| Apigenin | 2 | 2019 | 14 | 0.290 |
Why?
|
| Adenosine Triphosphate | 4 | 2017 | 205 | 0.280 |
Why?
|
| Oxidopamine | 2 | 2005 | 23 | 0.270 |
Why?
|
| Histone Deacetylases | 2 | 2018 | 61 | 0.270 |
Why?
|
| Oxidative Stress | 3 | 2013 | 990 | 0.260 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2025 | 147 | 0.260 |
Why?
|
| Nanoparticles | 1 | 2013 | 449 | 0.260 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 228 | 0.260 |
Why?
|
| PC12 Cells | 5 | 2019 | 93 | 0.260 |
Why?
|
| Nitric Oxide | 5 | 2018 | 381 | 0.250 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2015 | 128 | 0.250 |
Why?
|
| Cytoprotection | 2 | 2003 | 36 | 0.250 |
Why?
|
| Oxygen Consumption | 4 | 2012 | 111 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2020 | 310 | 0.240 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 267 | 0.240 |
Why?
|
| Isoenzymes | 3 | 2021 | 169 | 0.230 |
Why?
|
| Carboxylic Acids | 1 | 2025 | 15 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 189 | 0.230 |
Why?
|
| Cell Cycle | 3 | 2021 | 348 | 0.230 |
Why?
|
| Acetylcysteine | 3 | 2015 | 57 | 0.230 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 122 | 0.220 |
Why?
|
| Pyrroles | 1 | 2025 | 68 | 0.220 |
Why?
|
| Smoke | 1 | 2005 | 41 | 0.220 |
Why?
|
| Neurotoxins | 1 | 2005 | 55 | 0.220 |
Why?
|
| Oxidation-Reduction | 6 | 2012 | 448 | 0.220 |
Why?
|
| Allyl Compounds | 2 | 2015 | 53 | 0.220 |
Why?
|
| Ubiquinone | 1 | 2004 | 22 | 0.210 |
Why?
|
| Interferon-gamma | 4 | 2016 | 268 | 0.210 |
Why?
|
| Acetylcarnitine | 1 | 2003 | 7 | 0.210 |
Why?
|
| Protective Agents | 1 | 2003 | 26 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2012 | 458 | 0.200 |
Why?
|
| Hydroxydopamines | 1 | 2003 | 4 | 0.200 |
Why?
|
| NAD | 1 | 2003 | 45 | 0.200 |
Why?
|
| Gluconeogenesis | 1 | 2003 | 15 | 0.200 |
Why?
|
| Blotting, Western | 5 | 2012 | 884 | 0.190 |
Why?
|
| Brain Neoplasms | 3 | 2015 | 129 | 0.190 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 69 | 0.190 |
Why?
|
| Chlorides | 2 | 2013 | 59 | 0.190 |
Why?
|
| Gallic Acid | 2 | 2012 | 11 | 0.180 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 102 | 0.180 |
Why?
|
| Breast Feeding | 1 | 2023 | 123 | 0.180 |
Why?
|
| Excitatory Amino Acids | 1 | 2001 | 7 | 0.180 |
Why?
|
| Phytotherapy | 1 | 2021 | 78 | 0.180 |
Why?
|
| Isoquinolines | 1 | 2021 | 50 | 0.170 |
Why?
|
| Glutathione | 4 | 2018 | 170 | 0.170 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2001 | 93 | 0.170 |
Why?
|
| Paclitaxel | 1 | 2021 | 64 | 0.170 |
Why?
|
| Benzamides | 1 | 2021 | 78 | 0.170 |
Why?
|
| Tetrahydroisoquinolines | 2 | 2021 | 22 | 0.170 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 143 | 0.170 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 54 | 0.170 |
Why?
|
| Glutamic Acid | 1 | 2001 | 131 | 0.160 |
Why?
|
| Cyclotides | 1 | 2019 | 4 | 0.160 |
Why?
|
| Interleukin-1alpha | 2 | 2017 | 18 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2012 | 385 | 0.160 |
Why?
|
| Nerve Growth Factors | 1 | 2019 | 34 | 0.160 |
Why?
|
| Drug Interactions | 3 | 2012 | 151 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 223 | 0.150 |
Why?
|
| Nitrites | 4 | 2015 | 54 | 0.150 |
Why?
|
| Fish Oils | 1 | 1998 | 13 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 290 | 0.140 |
Why?
|
| RNA, Messenger | 4 | 2015 | 1265 | 0.140 |
Why?
|
| Neurites | 1 | 2018 | 40 | 0.140 |
Why?
|
| Smoking | 1 | 2005 | 1019 | 0.140 |
Why?
|
| Apoptosis | 4 | 2014 | 1541 | 0.140 |
Why?
|
| Food | 1 | 1998 | 102 | 0.140 |
Why?
|
| Female | 12 | 2023 | 24018 | 0.130 |
Why?
|
| Aerobiosis | 2 | 2009 | 15 | 0.130 |
Why?
|
| Anaerobiosis | 2 | 2009 | 17 | 0.130 |
Why?
|
| DNA Repair | 1 | 2018 | 196 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 50 | 0.130 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2016 | 26 | 0.130 |
Why?
|
| Ibuprofen | 1 | 2016 | 34 | 0.130 |
Why?
|
| Molecular Conformation | 1 | 2017 | 157 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2017 | 154 | 0.120 |
Why?
|
| DNA Damage | 1 | 2018 | 358 | 0.120 |
Why?
|
| Neutrophils | 1 | 2016 | 141 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2017 | 462 | 0.120 |
Why?
|
| Hela Cells | 1 | 2017 | 370 | 0.120 |
Why?
|
| Microtubules | 1 | 2016 | 120 | 0.120 |
Why?
|
| Manganese Compounds | 2 | 2013 | 15 | 0.120 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 10 | 0.120 |
Why?
|
| Silymarin | 1 | 2015 | 2 | 0.120 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1066 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 147 | 0.120 |
Why?
|
| Genes, p53 | 1 | 2015 | 28 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 59 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 98 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 436 | 0.110 |
Why?
|
| Histones | 2 | 2015 | 194 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2025 | 1420 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1617 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2014 | 88 | 0.100 |
Why?
|
| Molecular Structure | 3 | 2025 | 560 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2017 | 875 | 0.100 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2013 | 12 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2014 | 130 | 0.100 |
Why?
|
| Manganese Poisoning | 1 | 2013 | 16 | 0.100 |
Why?
|
| Sulfhydryl Compounds | 1 | 2013 | 49 | 0.100 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 1068 | 0.090 |
Why?
|
| DNA Fingerprinting | 1 | 2012 | 17 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 1998 | 188 | 0.090 |
Why?
|
| Heterochromatin | 1 | 2012 | 19 | 0.090 |
Why?
|
| Nucleosomes | 1 | 2012 | 31 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 78 | 0.090 |
Why?
|
| Time Factors | 3 | 2012 | 1848 | 0.090 |
Why?
|
| Particle Size | 1 | 2013 | 267 | 0.090 |
Why?
|
| Ligands | 1 | 2013 | 387 | 0.090 |
Why?
|
| Liliaceae | 1 | 2010 | 2 | 0.090 |
Why?
|
| Boraginaceae | 1 | 2010 | 2 | 0.090 |
Why?
|
| Apiaceae | 1 | 2010 | 3 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 19 | 0.090 |
Why?
|
| Melanins | 1 | 2011 | 42 | 0.080 |
Why?
|
| Kinetics | 2 | 2003 | 698 | 0.080 |
Why?
|
| Prostate | 1 | 2011 | 152 | 0.080 |
Why?
|
| Vitamins | 1 | 2011 | 81 | 0.080 |
Why?
|
| Nucleus Accumbens | 4 | 2000 | 99 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 230 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 57 | 0.080 |
Why?
|
| Corpus Striatum | 4 | 2000 | 119 | 0.080 |
Why?
|
| Alcohols | 1 | 2009 | 14 | 0.080 |
Why?
|
| Fermentation | 1 | 2009 | 38 | 0.080 |
Why?
|
| Ketones | 1 | 2009 | 18 | 0.080 |
Why?
|
| Aldehydes | 1 | 2009 | 69 | 0.080 |
Why?
|
| Amino Acids | 1 | 2009 | 150 | 0.070 |
Why?
|
| Piroxicam | 1 | 2008 | 2 | 0.070 |
Why?
|
| MPTP Poisoning | 1 | 2008 | 12 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2008 | 34 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2012 | 393 | 0.070 |
Why?
|
| Cell Line | 3 | 2015 | 1416 | 0.070 |
Why?
|
| Oxidants | 2 | 2005 | 43 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 457 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 1998 | 350 | 0.070 |
Why?
|
| Superoxides | 2 | 2004 | 57 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2018 | 89 | 0.060 |
Why?
|
| Sympatholytics | 1 | 2005 | 13 | 0.060 |
Why?
|
| Pyridinium Compounds | 1 | 2005 | 27 | 0.060 |
Why?
|
| Garlic | 2 | 2015 | 31 | 0.060 |
Why?
|
| Cell Respiration | 1 | 2004 | 35 | 0.050 |
Why?
|
| Electron Transport Complex III | 1 | 2004 | 13 | 0.050 |
Why?
|
| Motor Activity | 3 | 2008 | 438 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2004 | 102 | 0.050 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2003 | 13 | 0.050 |
Why?
|
| Phosphoenolpyruvate | 1 | 2003 | 4 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2025 | 491 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 456 | 0.050 |
Why?
|
| Propidium | 1 | 2003 | 20 | 0.050 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2023 | 35 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 37 | 0.050 |
Why?
|
| Monosaccharides | 1 | 2003 | 13 | 0.050 |
Why?
|
| Antiparkinson Agents | 1 | 2002 | 14 | 0.050 |
Why?
|
| Imines | 1 | 2002 | 9 | 0.050 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2002 | 10 | 0.050 |
Why?
|
| Levodopa | 1 | 2002 | 26 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2003 | 166 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 54 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 221 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2003 | 108 | 0.050 |
Why?
|
| Cell Death | 1 | 2003 | 277 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 574 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2000 | 1737 | 0.040 |
Why?
|
| Florida | 1 | 2023 | 461 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2001 | 45 | 0.040 |
Why?
|
| N-Methylaspartate | 1 | 2001 | 58 | 0.040 |
Why?
|
| Mothers | 1 | 2023 | 212 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 106 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2001 | 133 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2000 | 140 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2023 | 960 | 0.040 |
Why?
|
| Biomimetics | 1 | 2019 | 14 | 0.040 |
Why?
|
| Triazoles | 1 | 2000 | 100 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1143 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 48 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 599 | 0.040 |
Why?
|
| Quinolinic Acid | 1 | 1999 | 1 | 0.040 |
Why?
|
| Clorgyline | 1 | 1998 | 4 | 0.040 |
Why?
|
| Selegiline | 1 | 1998 | 6 | 0.040 |
Why?
|
| Sharks | 1 | 1998 | 2 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 53 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 1998 | 63 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 420 | 0.040 |
Why?
|
| Dopamine Antagonists | 1 | 1998 | 48 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 1998 | 41 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 183 | 0.030 |
Why?
|
| Inflammation | 1 | 2003 | 729 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2000 | 369 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 1998 | 98 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 1998 | 92 | 0.030 |
Why?
|
| Petroselinum | 1 | 2017 | 4 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 404 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 1998 | 221 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1998 | 170 | 0.030 |
Why?
|
| Tubulin | 1 | 2016 | 94 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 106 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1076 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 139 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 382 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 454 | 0.030 |
Why?
|
| Anthracenes | 1 | 2015 | 15 | 0.030 |
Why?
|
| Butadienes | 1 | 2015 | 29 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 31 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 96 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2015 | 6 | 0.030 |
Why?
|
| Etoposide | 1 | 2015 | 21 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Nitriles | 1 | 2015 | 78 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 452 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 105 | 0.030 |
Why?
|
| Child | 1 | 2023 | 3381 | 0.030 |
Why?
|
| Selenium | 1 | 1997 | 150 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 120 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 74 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 118 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2015 | 111 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 27 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 134 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 189 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cognition | 1 | 1998 | 458 | 0.030 |
Why?
|
| Male | 7 | 2012 | 22779 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 165 | 0.020 |
Why?
|
| Thymine | 1 | 2013 | 25 | 0.020 |
Why?
|
| Comet Assay | 1 | 2013 | 77 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 138 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 400 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 82 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2012 | 48 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 973 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 52 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2011 | 28 | 0.020 |
Why?
|
| Caspases | 1 | 2012 | 148 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 411 | 0.020 |
Why?
|
| Brain | 1 | 1998 | 1452 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 1169 | 0.020 |
Why?
|
| Pregnancy | 3 | 1998 | 1737 | 0.020 |
Why?
|
| Corticosterone | 2 | 1999 | 89 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 217 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 1804 | 0.010 |
Why?
|
| Catechols | 1 | 2002 | 7 | 0.010 |
Why?
|
| Free Radicals | 1 | 2002 | 72 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2002 | 45 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2002 | 158 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 522 | 0.010 |
Why?
|
| Tritium | 1 | 2000 | 51 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2000 | 23 | 0.010 |
Why?
|
| Amphetamine | 1 | 2000 | 21 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 153 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2000 | 81 | 0.010 |
Why?
|
| Naloxone | 1 | 1999 | 56 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 27 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1998 | 107 | 0.010 |
Why?
|
| Morphine | 1 | 1999 | 68 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 1998 | 59 | 0.010 |
Why?
|
| Maze Learning | 1 | 1998 | 112 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 207 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1998 | 83 | 0.010 |
Why?
|
| Homovanillic Acid | 1 | 1997 | 10 | 0.010 |
Why?
|
| Microdialysis | 1 | 1997 | 18 | 0.010 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1997 | 27 | 0.010 |
Why?
|
| Quinpirole | 1 | 1997 | 18 | 0.010 |
Why?
|
| Memory | 1 | 1998 | 175 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1998 | 253 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1998 | 318 | 0.010 |
Why?
|